BIOMARIN PHARMACEUTICAL INC·5

Feb 13, 6:52 PM ET

Davis George Eric 5

5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 13, 2026

Insider Transaction Report

Form 5
Period: 2025-12-31
Davis George Eric
EVP, Chief Legal Officer
Transactions
  • Award

    Common Stock

    [F1]
    2025-04-30$54.14/sh+375$20,30183,290 total
Footnotes (1)
  • [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-02-13

Documents

1 file
  • 5
    wk-form5_1771026723.xmlPrimary

    FORM 5